| KDNY Shares Outstanding History Table | ||||||||||||||||||||||||||||
Below is a table of the KDNY shares outstanding history going back to 10/2/2020:
Also see: KDNY Market Cap History KDNY YTD Return |
KDNY Shares Outstanding History — Chinook Therapeutics Share Count Over Time
As of 8/4/2023 Chinook Therapeutics has 71.80 million KDNY shares outstanding. Investors often track the KDNY shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows KDNY share count trends over time, with 13 historical shares outstanding datapoints presented, dating back to 10/2/2020.
| KDNY Shares Outstanding History Chart | |||||||||||||||||||||||||||||
KDNY Historical Shares Outstanding: +68.93% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||
| KDNY Stock Price Chart |
| About Chinook Therapeutics Inc |
| Chinook Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing precision medicines for kidney diseases. Co.'s pipeline is focused on kidney diseases with clinical pathways. Co.'s lead clinical program is atrasentan, an endothelin A receptor antagonist. Co.'s second product candidate, BION-1301, is an anti-APRIL monoclonal antibody also in development for patients with IgA nephropathy. Co. developing CHK-336 for the treatment of primary hyperoxaluria as well as secondary hyperoxaluria and idiopathic kidney stone formation. Co. is also conducting research programs in several other rare, severe chronic kidney diseases. We show 13 historical shares outstanding datapoints in our coverage of KDNY's shares outstanding history. Understanding the changing numbers of KDNY shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like KDNY versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching KDNY by allowing them to research KDNY shares outstanding history as well as any other stock in our coverage universe. |
| KDNY Current Stock Quote |
Quotes delayed 20 minutes  Free KDNY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| KDNY Share Performance |
| Shares Outstanding Peers |
| Chinook Therapeutics (KDNY) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
KEQU Shares Outstanding History KERX Shares Outstanding History KIDS Shares Outstanding History KIN Shares Outstanding History KLDO Shares Outstanding History KLRS Shares Outstanding History KMPH Shares Outstanding History KND Shares Outstanding History KNTE Shares Outstanding History KOD Shares Outstanding History More Healthcare companies » |
KDNY Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
